查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576505

生物反应器市场规模,占有率,预测,趋势分析：按类型、生物製程、效用、规模、细胞类型、应用、使用者 - 到 2031 年的全球预测

Bioreactors Market Size, Share, Forecast, & Trends Analysis by Type, Bioprocess, Usability, Scale, Cell Type, Application, User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 260 Pages | 商品交期: 5-7个工作天内

价格

预计到2031年，全球生物反应器市场将达到399.6亿美元，2024年至2031年复合年增长率为10.1%。

该报告基于全面的一手和二手研究以及对市场情景的深入分析，深入瞭解了生物反应器市场的关键推动因素、市场限制、机会和课题。市场成长的推动因素包括生物製药工厂的扩张、製药业的成长、药品研发支出的增加、生物相似药的采用增加以及製药和生物技术领域一次性技术的采用增加。然而，生物製药开发和製造过程的复杂性以及生物製药製造所需的高资本需求限制了市场成长。

此外，生物反应器技术的进步以及个人化药物以及细胞和基因疗法的更多采用预计将创造市场成长机会。然而，使用一次性生物反应器的生物製造过程中与可提取物和可浸出物(E&L) 相关的风险、扩大生物製药过程的限制、标准化一次性生物反应器设计的需要、与废弃生物反应器相关的环境问题是其中一些因素。

从产品来看，预计到 2024 年，连续搅拌釜生物反应器领域将占据生物反应器市场的最大占有率，达到 31%。该领域的巨大市场占有率归因于连续搅拌罐生物反应器的技术进步以及由于其与其他生物反应器相比具有优越的传热性能而能够处理高浓度反应物。此外，市场参与者正在增强生物反应器设计，以便与现有流动系统无缝整合。例如，2024年10月，Vapourtec Ltd.（英国）推出了专为连续製程合成而设计的连续搅拌槽生物反应器。

基于生物工艺，预计到 2024 年，分批/补料分批细分市场将占据生物反应器市场的最大占有率。此细分市场的庞大市场占有率归因于分批/补料分批生物製程的优势，例如高生产率、简化的生物製程管理和降低的污染风险。批次持续时间非常适合快速实验、加速上游流程和提高整体生产力。

按细胞类型划分，预计到 2024 年，哺乳动物细胞将在生物反应器市场中占据最大占有率。该细分市场的巨大市场占有率归因于对单株抗体和治疗性蛋白质等复杂生物分子的商业和研究生物生产的日益关注。此外，涉及哺乳动物细胞的临床研究的增长促使一次性生物反应器的广泛采用。

基于易用性，预计到 2024 年，可重复使用的生物反应器领域将在生物反应器市场中占据更大的占有率。该领域的巨大市场占有率归因于大规模製造的增加，而可重复使用的生物反应器由于其成本效益和适合大批量生产而得到越来越多的采用。此外，与废物处理相关的高成本和监管限制正在推动可重复使用生物反应器的广泛采用。

以规模计算，中试规模生物反应器（10L-200L）领域预计将创下市场最高复合年增长率。中试规模生物反应器是容量从 10L 到 200L 不等的系统，可提供多种变化和客製化。中试生物反应器在食品、製药和化妆品行业中有着广泛的应用，主要用于在大规模生产之前测试和完善生物製程。对商业生物生产的需求不断增长将推动中试规模生物加工的采用。这是因为这些生物反应器对于评估其在接近工业环境的条件下的效率、可扩展性和性能至关重要。

基于自动化，自动化生物反应器领域预计将在 2024 年占据更大的市场占有率。该细分市场的巨大市场占有率归因于自动化生物反应器提供的优势，例如提高製程品质、减少错误、优化製程控制和降低成本。自动化生物反应器透过即时监控和数据丰富的品质控制帮助提高品质和生产力。简化程序和实验并快速检测过程偏差。

从应用来看，预计到 2024 年商业生产领域将占据生物反应器市场的很大占有率。商业生产包括单株抗体 (mAb) 生产、细胞和基因治疗生产、疫苗生产、血浆分级分离和重组蛋白生产。该细分市场的巨大市场占有率是由生物製药的日益普及、旨在加速生物仿製药采用的有利监管改革以及基因疗法开发投资的增加所推动的。

从最终用户来看，生物製药製造商领域预计将在 2024 年占据最大占有率。近年来，由于生物製药需求的增加、慢性病盛行率的增加、製药和生物技术公司研发支出的增加以及最近针对慢性和罕见疾病的生物製剂的推出，生物製药製造商经历了显着增长。各国政府正在主动投资、向生物製药公司提供赠款和资金，用于生物製药的製造和研发，并共同开发可持续的生物製造方法。这些因素促使生物製药製造商扩大采用生物反应器，从而为该领域带来了巨大的市场占有率。

对全球生物反应器市场区域状况的详细分析为五个关键区域（北美、欧洲、亚太地区、中东和非洲以及拉丁美洲）以及每个区域的主要国家提供了详细的定性和定量见解。 。

到2024年，北美预计将占据全球生物反应器市场的最大占有率，达到34%，其次是欧洲、亚太地区、拉丁美洲以及中东和非洲。北美市场占有率大的原因在于主要生物製药公司的存在、研发投入高、政府和监管机构对促进生物製药使用的支持以及生物製药公司扩大生产能力的努力。

目录

第1章简介

第2章 研究方法

第3章 执行摘要

第4章 市场洞察

  • 概述
  • 促进因素
    • 生物製药工厂产能扩张
    • 医药市场的成长
    • 药品研发费用增加
    • 生物相似药的采用增加
    • 製药和生物技术产业扩大采用一次性技术
  • 阻碍因素
    • 生物製药的复杂开发与製造流程
    • 生物製药製造的密集资金需求
  • 机会
    • 生物反应器技术的进展
    • 更多采用个人化药物以及细胞和基因疗法
  • 任务
    • 使用一次性生物反应器的生物製造过程中的可萃取物和可浸出物 (E&L) 风险
    • 工艺放大限制
    • 一次性生物反应器设计标准化的必要性
    • 关于一次性生物反应器处置的环境问题
  • 科技趋势/市场趋势
    • 在商业生产中使用一次性加工设备
    • 越来越重视连续生物加工
    • 转向生物製程4.0
    • 将人工智慧融入生物加工
  • 监管场景
  • 价格分析
  • 母市场分析
  • 波特五力分析

第5章全球生物反应器市场：按类型

  • 概述
  • 连续搅拌槽生物反应器
  • 气升式生物反应器
  • 流体化床生物反应器
  • 填充床生物反应器
  • 光生物反应器
    • 开放式生物反应器
    • 封闭系统生物反应器
  • 膜生物反应器

第6章全球生物反应器市场：依生物製程分类

  • 概述
  • 分批/补料分批生物工艺
  • 连续生物过程

第7章全球生物反应器市场：依细胞类型

  • 概述
  • 哺乳动物细胞
  • 细菌细胞
  • 酵母细胞
  • 其他细胞类型

第8章全球生物反应器市场：依应用分类

  • 概述
  • 可重复使用的生物反应器
    • 不銹钢
    • 玻璃
  • 一次性生物反应器

第9章全球生物反应器市场：依规模

  • 概述
  • 实验室规模生物反应器（0.5L-10L）
  • 中试规模生物反应器（10L-200L）
  • 工业规模生物反应器
    • 200L 至 500L
    • 500L 至 1000L
    • 1,500L以上

第10章全球生物反应器市场：依应用分类

  • 概述
  • 商业化生产
    • 单株抗体 (mAb) 生产
    • 细胞/基因治疗製造
    • 疫苗生产
    • 血浆分数
    • 重组蛋白生产
  • 开发、临床前、临床

第11章全球生物反应器市场：依最终用户分类

  • 概述
  • 生物製药製造商
  • 研发机构
  • 合约製造组织

第12章生物反应器市场：按地区

  • 概述
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 瑞士
    • 爱尔兰
    • 丹麦
    • 比利时
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中东/非洲

第13章 竞争分析

  • 概述
  • 主要成长策略
  • 竞争标桿
  • 比赛仪表板
    • 市场领导者
    • 差异化因素
    • 龙头企业
    • 启动
  • 市场占有率分析（2023 年）

第14章 公司简介（公司概况、财务概况、产品组合、策略发展）

  • Thermo Fisher Scientific, Inc.
  • METTLER TOLEDO
  • Merck KGaA
  • Eppendorf AG
  • Sartorius AG
  • Danaher Corporation
  • Donaldson Company, Inc.
  • BBI-Biotech GmbH
  • Infors AG
  • Pharsol Ltd.
  • 其他公司

（註：提供前5名公司的SWOT分析）

第15章附录

Product Code: MRHC - 1041133

Bioreactors Market Size, Share, Forecast, & Trends Analysis by Type (continuous Stirred Tank, Photobioreactor) Bioprocess (Batch, Continuous) Usability (Reusable, Single-use) Scale (Pilot, Industrial) Cell Type, Application, User-Global Forecast to 2031.

The global bioreactors market is projected to reach $39.96 billion by 2031, at a CAGR of 10.1% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides insights into the key drivers, restraints, opportunities, and challenges of the bioreactors market. The growth of this market is driven by the expansion of biopharmaceutical plants, the growth of the pharmaceuticals sector, increased R&D expenditures in pharmaceuticals, the rising adoption of biosimilars, and the growing adoption of disposable technologies in the pharmaceutical and biotechnology sectors. However, the complex development & manufacturing processes of biopharmaceuticals and high capital requirements for biopharmaceutical production restrain the market's growth.

Moreover, advancements in bioreactor technologies and the rising adoption of personalized medicines and cell & gene therapies are expected to create market growth opportunities. However, risks associated with extractables and leachables (E&L) in biomanufacturing processes using single-use bioreactors, limitations in scaling up biopharmaceutical processes, the need to standardize designs for single-use bioreactors, and environmental concerns related to the disposal of single-use bioreactors are some of the challenges impacting the market's growth.

Based on product, in 2024, the continuous stirred-tank bioreactors segment is expected to account for the largest share of 31% of the bioreactors market. This segment's large market share can be attributed to technological advancements in continuous stirred-tank bioreactors and their capability to handle higher concentrations of reactants due to their superior heat transfer properties compared to other bioreactors. Additionally, market players are enhancing bioreactor designs to integrate seamlessly with existing flow systems. For instance, in October 2024, Vapourtec Ltd. (U.K.) launched a continuous stirred-tank bioreactor designed for continuous process synthesis, specifically designed to work alongside existing flow-chemistry systems.

Based on bioprocess, in 2024, the batch/fed-batch segment is expected to account for the largest share of the bioreactors market. This segment's large market share can be attributed to the advantages of batch/fed-batch bioprocessing, including high productivity, simplified management of bioprocesses, and reduced risks of contamination. The duration of batch processing is ideal for rapid experimentation and accelerates upstream processes, thereby enhancing overall productivity.

Based on cell type, in 2024, the mammalian cells segment is expected to account for the largest share of the bioreactors market. This segment's large market share can be attributed to the increasing focus on commercial and research bioproduction for complex biomolecules such as monoclonal antibodies and therapeutic proteins. Additionally, the growth in clinical research involving mammalian cells has led to their widespread adoption in single-use bioreactors.

Based on usability, in 2024, the reusable bioreactors segment is expected to account for the larger share of the bioreactors market. This segment's large market share can be attributed to the increase in large-scale manufacturing, where reusable bioreactors are increasingly adopted due to their cost efficiency and suitability for handling high volumes of production. Moreover, the high costs and regulatory restrictions associated with waste disposal drive the increased adoption of reusable bioreactors.

Based on scale, the pilot scale bioreactors (10L-200L) segment is slated to register the highest CAGR in the market. Pilot scale bioreactors are systems that are between the capacity of 10L-200L and include multiple variations and customizations. They find extensive application in the food, pharmaceutical, and cosmetics industries, primarily for testing and refining bioprocesses before full-scale production. The increasing demand for commercial bioproduction drives the adoption of pilot scale bioprocessing, as these bioreactors are crucial in assessing efficiency, scalability, and performance under conditions closely resembling industrial settings.

Based on automation, in 2024, the automated bioreactors segment is expected to account for the larger share of the market. This segment's large market share can be attributed to the benefits offered by automated bioreactors, including enhanced process quality, reduced errors, optimized process control, and cost savings. Automated bioreactors contribute to improved quality and productivity through real-time monitoring and data-rich quality control. They streamline procedures and experiments, ensuring swift detection of deviations in processes.

Based on application, in 2024, the commercial production segment is expected to account for the larger share of the bioreactors market. The commercial production consists of monoclonal antibodies (mAb) production, cell & gene therapy production, vaccine manufacturing, plasma fractionation, and recombinant protein production. This segment's large market share can be attributed to the growing adoption of biopharmaceuticals, favorable regulatory reforms aimed at promoting the adoption of biosimilars, and rising investments in developing gene therapies.

Based on end user, in 2024, the biopharmaceutical manufacturers segment is expected to account for the largest share of the market. Biopharmaceutical companies have witnessed significant growth in recent years due to the increasing demand for biopharmaceuticals, growing incidence of chronic diseases, rising R&D expenditure by pharmaceutical & biotechnology companies, and recent launches of biologics for chronic & rare diseases. Governments of various countries are taking initiatives by making investments and providing grants & funds to biopharmaceutical companies for the manufacture and R&D of biopharmaceuticals, along with several companies that are collaborating to develop sustainable methods for biomanufacturing. These factors contribute to the increased adoption of bioreactors among biopharmaceutical manufacturers, contributing to the segment's large market share.

An in-depth analysis of the geographical scenario of the global bioreactors market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.

In 2024, North America is expected to account for the largest share of 34% of the global bioreactors market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America's significant market share can be attributed to the presence of large biopharmaceutical companies, high R&D investments, support from government and regulatory authorities to promote the use of biopharmaceuticals, and initiatives by biopharmaceutical companies to expand their manufacturing capacities.

The key players operating in the global bioreactors market are Thermo Fisher Scientific, Inc. (U.S.), METTLER TOLEDO (U.S.), Merck KGaA (Germany), Eppendorf AG (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Donaldson Company, Inc. (U.S.), BBI-Biotech GmbH (Germany), Infors AG (Switzerland), and Pharsol Ltd. (Slovenia).

Scope of the Report:

Bioreactors Market-by Product

  • Continuous Stirred Tank Bioreactors
  • Airlift Bioreactors
  • Fluidized-bed Bioreactors
  • Packed-bed Bioreactors
  • Photobioreactors
    • Open System Photobioreactors
    • Closed System Photobioreactors
  • Membrane Bioreactors

Bioreactors Market-by Bioprocess

  • Batch/Fed-batch Bioprocessing
  • Continuous Bioprocessing

Bioreactors Market-by Cell Type

  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Other Cell Types

(Other cell types include plant cells and insect cells)

Bioreactors Market-by Usability

  • Reusable Bioreactors
    • Reusable Bioreactors by Material
  • Stainless Steel
  • Glass
  • Single-use Bioreactors

Bioreactors Market-by Scale

  • Lab Scale Bioreactors (0.5L-10L)
  • Pilot Scale Bioreactors (10L-200L)
  • Industrial Scale Bioreactors
    • 200L-500L
    • 500L-1000L
    • Above 1,500L

Bioreactors Market-by Automation

  • Manual/Semi-automated Bioreactors
  • Automated Bioreactors

Bioreactors Market-by Application

  • Commercial Production
    • Monoclonal Antibodies (mAb) Production
    • Cell & Gene Therapy Production
    • Vaccine Manufacturing
    • Plasma Fractionation
    • Recombinant Protein Production
  • Developmental, Preclinical, & Clinical

Bioreactors Market-by End User

  • Biopharmaceutical Manufacturers
  • Research & Development Organizations
  • Contract Manufacturing Organizations

Bioreactors Market-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Switzerland
    • Ireland
    • Denmark
    • Belgium
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumption for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Capacity Expansion of Biopharmaceutical Plants
    • 4.2.2. Growing Pharmaceutical Market
    • 4.2.3. Rising Pharmaceutical R&D Expenditures
    • 4.2.4. Rising Adoption of Biosimilars
    • 4.2.5. Growing Adoption of Disposable Technologies in the Pharmaceutical and Biotechnology Industries
  • 4.3. Restraints
    • 4.3.1. Complex Development and Manufacturing Process of Biopharmaceuticals
    • 4.3.2. Intensive Capital Requirements for Biopharmaceuticals Production
  • 4.4. Opportunities
    • 4.4.1. Technological Advancements in Bioreactor Technologies
    • 4.4.2. Rising Adoption of Personalized Medicines and Cell & Gene Therapies
  • 4.5. Challenges
    • 4.5.1. Risk of Extractables and Leachables (E&L) in Biomanufacturing Processes Using Single-use Bioreactors
    • 4.5.2. Process Scale-up Limitations
    • 4.5.3. Need to Standardize Single-use Bioreactor Designs
    • 4.5.4. Environmental Concerns Related to the Disposal of Single-use Bioreactors
  • 4.6. Technology Trends/Market Trends
    • 4.6.1. Use of Disposable Processing Equipment for Commercial Production
    • 4.6.2. Rising Focus on Continuous Bioprocessing
    • 4.6.3. Shift Towards Bioprocessing 4.0
    • 4.6.4. Integration of AI in Bioprocessing
  • 4.7. Regulatory Scenario
  • 4.8. Pricing Analysis
  • 4.9. Parent Market Analysis
  • 4.10 Porter's Five Forces Analysis

5. Global Bioreactors Market-by Type

  • 5.1. Overview
  • 5.2. Continuous Stirred-tank Bioreactors
  • 5.3. Airlift Bioreactors
  • 5.4. Fluidized-bed Bioreactors
  • 5.5. Packed-bed Bioreactors
  • 5.6. Photobioreactors
    • 5.6.1. Open System Bioreactors
    • 5.6.2. Closed System Bioreactors
  • 5.7. Membrane Bioreactors

6. Global Bioreactors Market-by Bioprocess

  • 6.1. Overview
  • 6.2. Batch/Fed-batch Bioprocessing
  • 6.3. Continuous Bioprocessing

7. Global Bioreactors Market-by Cell Type

  • 7.1. Overview
  • 7.2. Mammalian Cells
  • 7.3. Bacterial Cells
  • 7.4. Yeast Cells
  • 7.5. Other Cell Types

8. Global Bioreactors Market-by Usability

  • 8.1. Overview
  • 8.2. Reusable Bioreactors
    • 8.2.1. Stainless Steel
    • 8.2.2. Glass
  • 8.3. Single-use Bioreactors

9. Global Bioreactors Market-by Scale

  • 9.1. Overview
  • 9.2. Lab Scale Bioreactors (0.5L-10L)
  • 9.3. Pilot Scale Bioreactors (10L-200L)
  • 9.4. Industrial Scale Bioreactors
    • 9.4.1. 200L-500L
    • 9.4.2. 500L-1000L
    • 9.4.3. Above 1,500L

10. Global Bioreactors Market-by Application

  • 10.1. Overview
  • 10.2. Commercial Production
    • 10.2.1. Monoclonal Antibodies (mAb) Production
    • 10.2.2. Cell & Gene Therapy Production
    • 10.2.3. Vaccine Manufacturing
    • 10.2.4. Plasma Fractionation
    • 10.2.5. Recombinant Protein Production
  • 10.3. Development, Preclinical, & Clinical

11. Global Bioreactors Market-by End User

  • 11.1. Overview
  • 11.2. Biopharmaceutical Manufacturers
  • 11.3. Research & Development Organizations
  • 11.4. Contract Manufacturing Organizations

12. Bioreactors Market-by Geography

  • 12.1. Overview
  • 12.2. North America
    • 12.2.1. U.S.
    • 12.2.2. Canada
  • 12.3. Europe
    • 12.3.1. Germany
    • 12.3.2. France
    • 12.3.3. U.K.
    • 12.3.4. Italy
    • 12.3.5. Spain
    • 12.3.6. Switzerland
    • 12.3.7. Ireland
    • 12.3.8. Denmark
    • 12.3.9. Belgium
    • 12.3.10. Rest of Europe
  • 12.4. Asia-Pacific
    • 12.4.1. Japan
    • 12.4.2. China
    • 12.4.3. India
    • 12.4.4. South Korea
    • 12.4.5. Rest of Asia Pacific
  • 12.5. Latin America
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Middle East & Africa

13. Competition Analysis

  • 13.1. Overview
  • 13.2. Key Growth Strategies
  • 13.3. Competitive Benchmarking
  • 13.4. Competitive Dashboard
    • 13.4.1. Market Leaders
    • 13.4.2. Market Differentiators
    • 13.4.3. Vanguards
    • 13.4.4. Emerging Companies
  • 13.5. Market Share Analysis (2023)

14. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 14.1. Thermo Fisher Scientific, Inc.
  • 14.2. METTLER TOLEDO
  • 14.3. Merck KGaA
  • 14.4. Eppendorf AG
  • 14.5. Sartorius AG
  • 14.6. Danaher Corporation
  • 14.7. Donaldson Company, Inc.
  • 14.8. BBI-Biotech GmbH
  • 14.9. Infors AG
  • 14.10. Pharsol Ltd.
  • 14.11. Other Companies

(Note: SWOT analysis of the top 5 companies will be provided.)

15. Appendix

  • 15.1. Available Customization
  • 15.2. Related Reports

LIST OF TABLES

  • Table 1 Global Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 2 Global Continuous Stirred-tank Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 3 Global Airlift Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 4 Global Fluidized-bed Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 5 Global Packed-bed Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 6 Global Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 7 Global Photobioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Global Open System Photobioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 9 Global Closed System Photobioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 10 Global Membrane Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 12 Global Batch/Fed-batch Bioprocessing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 13 Global Continuous Bioprocessing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 15 Global Bioreactors Market for Mammalian Cells, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Bioreactors Market for Bacterial Cells, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Bioreactors Market for Yeast Cells, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Bioreactors Market for Other Cells, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 20 Global Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 21 Global Reusable Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Stainless Steel based Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global Glass-based Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 24 Global Single-use Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Global Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 26 Global Lab Scale Bioreactors (0.5L-10L) Market, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global Pilot Scale Bioreactors (10L-200L) Market, by Country/Region, 2022-2031 (USD Million)
  • Table 28 Global Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 29 Global Industrial Scale Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Global 200L-500L Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 31 Global 500L-1000L Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Above 1,500L Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 34 Global Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 35 Global Monoclonal Antibodies (mAb) Production Market, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global Cell & Gene Therapy Production Market, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Global Vaccine Manufacturing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 38 Global Plasma Fractionation Market, by Country/Region, 2022-2031 (USD Million)
  • Table 39 Global Recombinant Protein Production Market, by Country/Region, 2022-2031 (USD Million)
  • Table 40 Global Bioreactors Market for Developmental, Preclinical & Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 41 Global Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 42 Global Bioreactors Market for Biopharmaceutical Manufacturers, by Country/Region, 2022-2031 (USD Million)
  • Table 43 Global Bioreactors Market for Research & Development Organizations, by Country/Region, 2022-2031 (USD Million)
  • Table 44 Global Bioreactors Market for Contract Manufacturing Organizations, by Country/Region, 2022-2031 (USD Million)
  • Table 45 Global Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 46 North America: Bioreactors Market, by Country, 2022-2031 (USD Million)
  • Table 47 North America: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 48 North America: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 49 North America: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 50 North America: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 51 North America: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 52 North America: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 53 North America: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 54 North America: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 55 North America: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 56 North America: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 57 North America: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 58 U.S.: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 59 U.S.: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 60 U.S.: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 61 U.S.: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 62 U.S.: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 63 U.S.: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 64 U.S.: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 65 U.S.: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 66 U.S.: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 67 U.S.: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 68 U.S.: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 69 Canada: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 70 Canada: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 71 Canada: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 72 Canada: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 73 Canada: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 74 Canada: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 75 Canada: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 76 Canada: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 77 Canada: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 78 Canada: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 79 Canada: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 80 Europe: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 81 Europe: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 82 Europe: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 83 Europe: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 84 Europe: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 85 Europe: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 86 Europe: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 87 Europe: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 88 Europe: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 89 Europe: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 90 Europe: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 91 Europe: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 92 Germany: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 93 Germany: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 94 Germany: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 95 Germany: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 96 Germany: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 97 Germany: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 98 Germany: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 99 Germany: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 100 Germany: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 101 Germany: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 102 Germany: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 103 France: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 104 France: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 105 France: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 106 France: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 107 France: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 108 France: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 109 France: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 110 France: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 111 France: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 112 France: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 113 France: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 114 U.K.: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 115 U.K.: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 116 U.K.: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 117 U.K.: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 118 U.K.: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 119 U.K.: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 120 U.K.: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 121 U.K.: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 122 U.K.: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 123 U.K.: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 124 U.K.: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 125 Italy: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 126 Italy: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 127 Italy: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 128 Italy: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 129 Italy: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 130 Italy: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 131 Italy: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 132 Italy: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 133 Italy: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 134 Italy: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 135 Italy: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 136 Spain: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 137 Spain: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 138 Spain: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 139 Spain: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 140 Spain: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 141 Spain: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 142 Spain: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 143 Spain: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 144 Spain: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 145 Spain: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 146 Spain: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 147 Switzerland: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 148 Switzerland: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 149 Switzerland: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 150 Switzerland: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 151 Switzerland: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 152 Switzerland: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 153 Switzerland: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 154 Switzerland: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 155 Switzerland: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 156 Switzerland: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 157 Switzerland: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 158 Ireland: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 159 Ireland: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 160 Ireland: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 161 Ireland: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 162 Ireland: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 163 Ireland: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 164 Ireland: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 165 Ireland: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 166 Ireland: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 167 Ireland: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 168 Ireland: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 169 Denmark: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 170 Denmark: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 171 Denmark: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 172 Denmark: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 173 Denmark: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 174 Denmark: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 175 Denmark: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 176 Denmark: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 177 Denmark: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 178 Denmark: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 179 Denmark: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 180 Belgium: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 181 Belgium: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 182 Belgium: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 183 Belgium: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 184 Belgium: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 185 Belgium: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 186 Belgium: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 187 Belgium: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 188 Belgium: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 189 Belgium: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 190 Belgium: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 191 Rest of Europe: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 192 Rest of Europe: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 193 Rest of Europe: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 194 Rest of Europe: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 195 Rest of Europe: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 196 Rest of Europe: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 197 Rest of Europe: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 198 Rest of Europe: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 199 Rest of Europe: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 200 Rest of Europe: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 201 Rest of Europe: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 202 Asia-Pacific: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 203 Asia-Pacific: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 204 Asia-Pacific: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 205 Asia-Pacific: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 206 Asia-Pacific: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 207 Asia-Pacific: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 208 Asia-Pacific: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 209 Asia-Pacific: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 210 Asia-Pacific: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 211 Asia-Pacific: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 212 Asia-Pacific: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 213 Asia-Pacific: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 214 Japan: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 215 Japan: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 216 Japan: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 217 Japan: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 218 Japan: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 219 Japan: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 220 Japan: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 221 Japan: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 222 Japan: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 223 Japan: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 224 Japan: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 225 China: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 226 China: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 227 China: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 228 China: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 229 China: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 230 China: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 231 China: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 232 China: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 233 China: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 234 China: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 235 China: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 236 India: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 237 India: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 238 India: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 239 India: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 240 India: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 241 India: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 242 India: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 243 India: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 244 India: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 245 India: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 246 India: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 247 South Korea: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 248 South Korea: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 249 South Korea: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 250 South Korea: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 251 South Korea: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 252 South Korea: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 253 South Korea: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 254 South Korea: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 255 South Korea: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 256 South Korea: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 257 South Korea: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 258 Rest of Asia-Pacific: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 259 Rest of Asia-Pacific: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 260 Rest of Asia-Pacific: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 261 Rest of Asia-Pacific: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 262 Rest of Asia-Pacific: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 263 Rest of Asia-Pacific: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 264 Rest of Asia-Pacific: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 265 Rest of Asia-Pacific: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 266 Rest of Asia-Pacific: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 267 Rest of Asia-Pacific: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 268 Rest of Asia-Pacific: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 269 Latin America: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 270 Latin America: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 271 Latin America: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 272 Latin America: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 273 Latin America: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 274 Latin America: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 275 Latin America: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 276 Latin America: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 277 Latin America: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 278 Latin America: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 279 Latin America: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 280 Latin America: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 281 Brazil: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 282 Brazil: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 283 Brazil: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 284 Brazil: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 285 Brazil: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 286 Brazil: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 287 Brazil: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 288 Brazil: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 289 Brazil: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 290 Brazil: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 291 Brazil: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 292 Mexico: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 293 Mexico: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 294 Mexico: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 295 Mexico: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 296 Mexico: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 297 Mexico: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 298 Mexico: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 299 Mexico: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 300 Mexico: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 301 Mexico: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 302 Mexico: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 303 Rest of Latin America: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 304 Rest of Latin America: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 305 Rest of Latin America: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 306 Rest of Latin America: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 307 Rest of Latin America: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 308 Rest of Latin America: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 309 Rest of Latin America: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 310 Rest of Latin America: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 311 Rest of Latin America: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 312 Rest of Latin America: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 313 Rest of Latin America: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 314 Middle East & Africa: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 315 Middle East & Africa: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 316 Middle East & Africa: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 317 Middle East & Africa: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 318 Middle East & Africa: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 319 Middle East & Africa: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 320 Middle East & Africa: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 321 Middle East & Africa: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 322 Middle East & Africa: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 323 Middle East & Africa: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 324 Middle East & Africa: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 325 Middle East & Africa: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 326 Recent Developments, by Company, 2020-2024

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Bioreactors Market, by Type, 2024 VS. 2031 (USD Million)
  • Figure 8 Global Bioreactors Market, by Bioprocess, 2024 VS. 2031 (USD Million)
  • Figure 9 Global Bioreactors Market, by Cell Type, 2024 VS. 2031 (USD Million)
  • Figure 10 Global Bioreactors Market, by Usability, 2024 VS. 2031 (USD Million)
  • Figure 11 Global Bioreactors Market, by Scale, 2024 VS. 2031 (USD Million)
  • Figure 12 Global Bioreactors Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 13 Global Bioreactors Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 14 Global Bioreactors Market, by Geography
  • Figure 15 Global Bioreactors Market, by Product, 2024 VS. 2031 (USD Million)
  • Figure 16 Global Bioreactors Market, by Bioprocess, 2024 VS. 2031 (USD Million)
  • Figure 17 Global Bioreactors Market, by Cell Type, 2024 VS. 2031 (USD Million)
  • Figure 18 Global Bioreactors Market, by Usability, 2024 VS. 2031 (USD Million)
  • Figure 19 Global Bioreactors Market, by Scale, 2024 VS. 2031 (USD Million)
  • Figure 20 Global Bioreactors Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 21 Global Bioreactors Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 22 Global Bioreactors Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 23 North America: Bioreactors Market Snapshot
  • Figure 24 Europe: Bioreactors Market Snapshot
  • Figure 25 Asia-Pacific: Bioreactors Market Snapshot
  • Figure 26 Latin America: Bioreactors Market Snapshot
  • Figure 27 Key Growth Strategies Adopted by Leading Players, 2020-2024
  • Figure 28 Global Bioreactors Market: Competitive Benchmarking, by Product
  • Figure 29 Global Bioreactors Market: Competitive Dashboard
  • Figure 30 Global Bioreactors Market: Market Share Analysis/Market Ranking (2024)
  • Figure 31 Thermo Fisher Scientific, Inc.: Financial Overview (2024)
  • Figure 32 Merck KGaA: Financial Overview (2024)
  • Figure 33 Eppendorf AG: Financial Overview (2022)
  • Figure 34 Sartorius AG: Financial Overview (2022)
  • Figure 35 Danaher Corporation: Financial Overview (2024)
  • Figure 36 Donaldson Company, Inc.: Financial Overview (2024)